🇺🇸 FDA
Patent

US 11813310

Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia

granted A61KA61K38/00A61K38/193

Quick answer

US patent 11813310 (Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia) held by ILKOGEN ILAÇ SANAYI VE TICARET A.S. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ILKOGEN ILAÇ SANAYI VE TICARET A.S.
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/193, A61K47/68, A61P